What is Lark?
Headquartered in Mountain View, California, Lark operates at the intersection of artificial intelligence and chronic disease management. By leveraging sophisticated AI coaching, smart device integration, and continuous tele-monitoring, the company provides a scalable solution for health systems and payers aiming to improve patient outcomes. Lark's platform is designed to address the growing demand for remote, data-informed healthcare, positioning the firm as a critical infrastructure provider in the digital health ecosystem. Its business model focuses on reducing the burden of chronic conditions through proactive, personalized engagement, which has attracted significant interest from both venture capital and private equity entities.
How much funding has Lark raised?
Lark has raised a total of $198.2M across 8 funding rounds:
Unspecified
$1M
Series A
$3M
Private Equity
$3.1M
Series B
$20M
Multiple Rounds
$71M
Series D
$100M
Unspecified (2011): $1M with participation from Lightspeed Venture Partners
Series A (2013): $3M, investors not publicly disclosed
Private Equity (2013): $3.1M supported by Fenox Venture Capital
Series B (2017): $20M, investors not publicly disclosed
Debt (2020): $1M backed by PPP
Series C (2020): $55M with participation from King River Capital Pty Ltd
Debt (2020): $15M led by Trinity Capital and Bridge Bank.
Series D (2021): $100M supported by Franklin Templeton, PFM Health Sciences, King River Capital, and Deerfield
Key Investors in Lark
Lightspeed Venture Partners
A global multistage venture capital firm that partners with founders from seed through IPO, focusing on enterprise software, consumer, and infrastructure sectors.
King River Capital
A venture capital firm that invests in high-growth technology businesses globally, providing flexible capital and strategic advice to solve critical market problems.
Deerfield
An investment firm dedicated to advancing healthcare through a combination of capital, intelligence, and philanthropy, supporting innovation across the healthcare ecosystem.
What's next for Lark?
Following its latest major strategic investment, Lark is well-positioned to accelerate its product development and expand its footprint in the enterprise health market. The company's focus will likely shift toward deepening its AI capabilities and enhancing its tele-monitoring suite to support more complex patient populations. As the digital health industry matures, Lark's ability to integrate seamlessly into existing clinical workflows will be paramount. Investors are closely monitoring the company's capacity to maintain its growth momentum while navigating the evolving regulatory environment for virtual care, ensuring that its technological advancements translate into measurable clinical and financial efficiencies for its enterprise partners.
See full Lark company page
